<DOC>
	<DOCNO>NCT00983437</DOCNO>
	<brief_summary>The primary objective study evaluate safety tolerability long-term ( 12 month ) armodafinil treatment patient excessive sleepiness associate mild moderate close traumatic brain injury ( TBI ) .</brief_summary>
	<brief_title>Study Evaluate Safety , Tolerability , Efficacy Armodafinil Treatment Patients With Excessive Sleepiness Associated With Mild Moderate Closed Traumatic Brain Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<criteria>Patients enrol study rollover patient ( complete previous doubleblind efficacy study C10953/3067/ES/MN ) new patient ( participate C10953/3067/ES/MN study ) . Inclusion Criteria ( New Patients ) : The patient mild ( Glasgow Coma Scale [ GCS ] score = 1315 ) moderate ( GCS score = 912 ) close traumatic brain injury ( TBI ) time injury , injury occur 1 10 year prior screen . The patient Glasgow Outcome Scale score 5 . The patient Epworth Sleepiness Scale ( ESS ) score least 10 . The patient mean sleep latency Multiple Sleep Latency Test ( MSLT ) ( average 4 nap ) less 8 minute . The patient Clinical Global Impression Severity Illness ( CGIS ) rating relate excessive sleepiness 4 . The patient complaint excessive sleepiness ( least 5 days/week average ) least 3 month , excessive sleepiness begin within 12 month TBI identify accord first inclusion criterion . Written inform consent obtain . If admit inpatient treatment facility , patient discharge least 1 month prior screen visit . The patient medical psychiatric disorder could account excessive sleepiness . Women childbearing potential ( surgically sterile 2 year postmenopausal ) , use medically accepted method contraception , continue use 1 method duration study ( 30 day participation study ) . The patient otherwise good health , judge investigator , basis medical psychiatric history , physical examination , electrocardiogram ( ECG ) , serum chemistry , hematology , urinalysis . The patient willing able comply study restriction attend regularly schedule clinic visit specify protocol . The patient minimental state examination ( MMSE ) score 26 screen visit . The patient stable dosage medication ( allow protocol ) minimum 3 month ( selective serotonin reuptake inhibitor [ SSRIs ] serotonin norepinephrine reuptake inhibitor [ SNRIs ] ) , 8 week ( contraceptive ) , 4 week ( allow medication ) screen visit likely require change therapy least 12 week basis investigator ' assessment . The patient head injury , base medical record documentation history patient reliable informant ( available ) , temporally related onset worsen excessive sleepiness . The patient head injury fulfil criterion TBI within ±1 year TBI identify accord first inclusion criterion . The patient habitual bedtime 2100 2400 . Inclusion Criteria ( Rollover Patients Study C10953/3067/ES/MN ) : The patient complete 12 week doubleblind treatment Study C10953/3067/ES/MN . Written inform consent obtain . Women childbearing potential ( surgically sterile 2 year postmenopausal ) , use medically accepted method contraception agree continue use 1 method duration study 30 day participation study . The patient otherwise good health , judge investigator , basis medical psychiatric history , physical examination , ECG , serum chemistry , hematology , urinalysis . The patient willing able comply study restriction remain clinic require duration study period , willing return clinic followup evaluation specify protocol . Exclusion Criteria ( New Patients ) : The patient history 2 episodes transient loss consciousness without clear medical explanation , history know suspected pseudo seizure ( psychogenic seizure ) . Patients history seizure epilepsy may eligible follow discussion medical monitor . The patient require , likely require , treatment anticonvulsant medication study ; take anticonvulsant medication within 6 month screen visit . The patient unstable uncontrolled medical ( include illness related cardiovascular , renal , hepatic system ) surgical condition ( treat untreated ) suitable candidate treatment armodafinil , judge investigator . The patient neurosurgery involve brain brainstem . The patient history schizophrenia , bipolar disorder , psychotic depression , psychotic episode . The patient current Axis I disorder ( include depression posttraumatic stress disorder [ PTSD ] ) , assess Structured Clinical Interview Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( SCID ) . Patients Axis II disorder , opinion investigator , would affect patient participation study full compliance study procedure . The patient history , currently meet The International Classification Sleep Disorders , Edition 2 ( ICSD2 ) criterion sleep disorder associate excessive daytime sleepiness ; patient history idiopathic hypersomnia , insomnia ( require treatment ) , sleep disorder development TBI . The patient 85 % less sleep efficiency ( sleep duration ÷ time bed x 100 % ) determine Nocturnal Polysomnography ( NPSG ) . The patient disorder may interfere drug absorption , distribution , metabolism , excretion . The patient use medication include overthecounter ( OTC ) medicine disallow protocol within 7 day 5 halflives ( medication active metabolite ) , whichever longer . The patient need chronic pain medication . In judgment investigator , patient clinically significant deviation normal physical examination . In judgment investigator , patient clinically significant ECG finding . The patient diagnosis type dementia . The patient history suicidal ideation ( consider investigator clinical significance ) , suicidal . The patient know hypersensitivity armodafinil , racemic modafinil , component study drug tablet . Armodafinil tablet contain follow inactive ingredient : croscarmellose sodium , lactose , magnesium stearate , microcrystalline cellulose , povidone , pregelatinized starch . The patient history clinically significant cutaneous drug reaction , history clinically significant hypersensitivity reaction , include multiple allergy drug reaction . The patient clinical laboratory test value ( ) outside range ( ) specify protocol ( clinically significant laboratory abnormality ) , medical monitor provide write approval study participation . The subject history ( within past 5 year ) alcohol , narcotic , drug abuse ( exception nicotine ) define Diagnostic Statistical Manual Mental Disorders American Psychiatric Association , 4th Edition ( DSMIVTR ) patient current evidence substance use , without medical explanation , confirm result urine drug screen ( UDS ) . The patient take armodafinil , modafinil , stimulant medication excessive sleepiness within 1 month screen visit . The patient pregnant lactate woman . The patient know test positive human immunodeficiency virus ( HIV ) . The patient consumes average 600 mg caffeine per day , include coffee , tea and/or caffeinecontaining beverage food . The patient use investigational drug within 1 month screen visit . The patient receive workman 's compensation active litigation regard TBI . The patient SelfReported Hamilton Depression Rating Scale , 6 Item Version ( SHAMD6 ) score 4 . Exclusion Criteria ( Rollover Patients Study C10953/3067/ES/MN ) : The patient clinically significant unstable uncontrolled medical , surgical , psychiatric condition ( treat untreated ) may suitable candidate treatment armodafinil , judge investigator medical monitor . The patient current evidence active psychosis , include stimulantinduced psychosis mania . The patient current evidence nonmedical substance use confirm result UDS . The patient use medication include OTC medicine disallow protocol ( except armodafinil use study 3067 ) within 7 day 5 halflives drug active metabolite , whichever longer . The patient clinically significant deviation normal physical examination judge investigator . The patient clinically significant laboratory abnormality , judge investigator , without prior write approval medical monitor . The patient hypersensitivity armodafinil modafinil , excipients either . The patient pregnant lactate woman . The patient unlikely comply study protocol , unsuitable reason , judge investigator . The patient consumes average 600 mg caffeine per day ( approximately equivalent 5 cup coffee ) , include coffee , tea , and/or caffeinecontaining beverage food .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>